A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer

Objectives: The objective of our study was to assess the prognostic significance of the Pan-Immune-Inflammation Value (PIV) before concurrent chemoradiation (C-CRT) and prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer (SCLC). Methods: The medical records o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucuk, Ahmet, Topkan, Erkan, Ozkan, Emine Elif, Ozturk, Duriye, Pehlivan, Berrin, Selek, Ugur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331221/
https://www.ncbi.nlm.nih.gov/pubmed/37404137
http://dx.doi.org/10.1177/03946320231187759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331221/
https://www.ncbi.nlm.nih.gov/pubmed/37404137
http://dx.doi.org/10.1177/03946320231187759

Ejemplares similares